Drug intelligence / Profile preview

platelet-rich plasma lysate

Development stage
Phase 2
Lead developer
Taichung Veterans General Hospital
Modality
Cell Therapies
Administration
Intralesional
01

Overview

Platelet-rich plasma (PRP) lysate is an autologous or allogeneic biological preparation derived from platelet-rich plasma that has been subjected to a lysis process, such as freeze-thaw cycles, to release the intracellular and alpha-granule contents of platelets. This process results in a concentrated mixture of growth factors, including platelet-derived growth factor (PDGF), transforming growth factor-beta (TGF-β), vascular endothelial growth factor (VEGF), epidermal growth factor (EGF), and insulin-like growth factor 1 (IGF-1). Unlike standard PRP, the lysate form provides pre-released growth factors for immediate tissue interaction without requiring thrombin activation or intact platelets. It is currently being investigated as an intralesional injection for the treatment of partial-thickness rotator cuff tears, where it aims to stimulate tendon fibroblasts and local tissue cells to promote repair and regeneration.

Other names
platelet-rich plasma lysatePRP lysatelyophilized platelet-rich plasma lysateplatelet lysate

Beyond the preview

Go deeper on platelet-rich plasma lysate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on platelet-rich plasma lysate.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call